Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-027688

Chief Executive Officer sold 5,678 shares at $152.04 ($863,281)

  • Chief Executive Officer acquired 5,678 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-15 Exercise or conversion : show line 1 in the form 10b5-1 +5,678 $57.76 $327,961 446,664 D
2023-11-15 Sale : show line 2 in the form 10b5-1 −5,678 $152.04 $863,281 440,986 D
Open-market sales · 5,678 sh · avg $152.04 · $863,281

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-15 Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options −5,678 3,462 D
Loading xslF345X05/form4.xml…